G蛋白通路抑制因子2促进肝癌细胞HepG2增殖和迁移OACSTPCD
GPS2 promotes proliferation and migration of HepG2 cells
目的 探究G蛋白通路抑制因子2(GPS2)对肝癌细胞HepG2增殖和迁移的影响,并揭示其可能的作用机制.方法 通过肿瘤基因组图谱(TCGA)和临床蛋白质组肿瘤分析协作组(CPTAC)在线数据库分析GPS2表达情况;利用慢病毒感染HepG2细胞建立干涉及过表达GPS2的稳定株;利用Western印迹及实时荧光定量PCR(qPCR)检测GPS2蛋白及mRNA表达水平;利用细胞增殖实验检测干涉及过表达GPS2后对HepG2细胞增殖能力的影响;采用Transwell实验及细胞划痕实验检测干涉及过表达GPS2对HepG2细胞迁移能力的影响;采用qPCR实验检测干涉及过表达GPS2对HepG2细胞上皮间质转化(EMT)标志物和基质金属蛋白酶(MMP)表达的影响;通过Western印迹检测干涉及过表达GPS2对丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)通路和磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/AKT)通路的影响.结果 通过TCGA和CPTAC在线数据库分析发现,GPS2在人肝癌组织中高表达.干涉GPS2抑制HepG2细胞的增殖和迁移,而过表达GPS2促进HepG2细胞的增殖和迁移.干涉GPS2上调E钙黏蛋白(E-CAD)的mRNA水平,下调N钙黏蛋白(N-CAD)、波形蛋白(Vim)、MMP2和MMP9的mRNA水平,并抑制AKT和ERK磷酸化;相反,过表达GPS2下调E-CAD的mRNA水平,上调N-CAD、Vim、MMP2和MMP9的mRNA水平,并促进AKT和ERK磷酸化.结论 GPS2可以增强肝癌细胞MAPK/ERK和PI3K/AKT信号通路活化,促进EMT过程并上调MMP表达,提高HepG2细胞的增殖和迁移能力.
Objective To explore the effect of G-protein pathway suppressor 2(GPS2)on the proliferation and migration of HepG2 cells and the underlying mechanism.Methods GPS2 expression was analyzed via The Cancer Genome Atlas(TCGA)and Clinical Proteomic Tumor Analysis Consortium(CPTAC)online database.HepG2 cells with stable knockdown or overexpression of GPS2 were established with lentivirus.The protein and mRNA expression levels of GPS2 were detected by Western blotting and real-time quantitative PCR(qPCR)while cell proliferation was verified by cell proliferation assay.Cell migration was tested by Transwell and scratch assay.Epithelial-mesenchymal transition(EMT)biomarkers and the expression of matrix metalloproteinase(MMP)were detected by qPCR.Finally,the expressions of phosphorylation of protein kinase B(AKT)(p-AKT)and phosphorylation of extracellular signal-regulated kinase(ERK)(p-ERK)were detected by Western blotting.Results Based on the analysis of TCGA and CPTAC online database,GPS2 was highly expressed in human liver cancer tissues.Knockdown of GPS2 inhibited the proliferation and migration of HepG2 cells,while overexpression of GPS2 promoted the proliferation and migration of HepG2 cells.Silence of GPS2 up-regulated the mRNA level of E-cadherin(E-CAD),down-regulated the mRNA levels of N-cadherin(N-CAD),Vimentin(VIM),MMP2 and MMP9,and reduced the p-AKT and p-ERK.In contrast,overexpression of GPS2 decreased the mRNA level of E-CAD,increased the mRNA levels of N-CAD,VIM,MMP2 and MMP9,and elevated the protein levels of p-AKT and p-ERK.Conclusion GPS2 can promote the proliferation and migration of HepG2 cells,which might be attributed to increased activation of MAPK/ERK and PI3K/AKT signaling pathways and the EMT process.
陆莹;向慎思;詹轶群;杨晓明;尹荣华
北京工业大学环境与生命学部,北京 100124||军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850
临床医学
G蛋白通路抑制因子2HepG2细胞细胞增殖细胞迁移上皮间质转换基质金属蛋白酶
G-protein pathway suppressor 2HepG2cell proliferationcell migrationepithelial-mesenchymal transitionmatrix metalloproteinase
《军事医学》 2024 (008)
572-578 / 7
国家自然科学基金项目(82170403)
评论